CN109195612A - 可用于过敏反应治疗的细菌菌株的选择 - Google Patents

可用于过敏反应治疗的细菌菌株的选择 Download PDF

Info

Publication number
CN109195612A
CN109195612A CN201780028567.1A CN201780028567A CN109195612A CN 109195612 A CN109195612 A CN 109195612A CN 201780028567 A CN201780028567 A CN 201780028567A CN 109195612 A CN109195612 A CN 109195612A
Authority
CN
China
Prior art keywords
bacterial strain
dagk
strain
bacterium bacterial
bacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201780028567.1A
Other languages
English (en)
Chinese (zh)
Inventor
J.维萨洛维克
B.莫勒斯坦姆
B.加内施
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biogaya
Original Assignee
Biogaya
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogaya filed Critical Biogaya
Publication of CN109195612A publication Critical patent/CN109195612A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN201780028567.1A 2016-05-09 2017-05-08 可用于过敏反应治疗的细菌菌株的选择 Pending CN109195612A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE1650620-6 2016-05-09
SE1650620 2016-05-09
PCT/SE2017/050455 WO2017196235A1 (en) 2016-05-09 2017-05-08 Selection of bacterial strains useful in allergy treatment

Publications (1)

Publication Number Publication Date
CN109195612A true CN109195612A (zh) 2019-01-11

Family

ID=58873850

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780028567.1A Pending CN109195612A (zh) 2016-05-09 2017-05-08 可用于过敏反应治疗的细菌菌株的选择

Country Status (11)

Country Link
US (2) US11135255B2 (enExample)
EP (1) EP3454874A1 (enExample)
JP (1) JP7030716B2 (enExample)
CN (1) CN109195612A (enExample)
AU (1) AU2017262408A1 (enExample)
BR (1) BR112018072511A2 (enExample)
CA (1) CA3023867A1 (enExample)
CL (1) CL2018003167A1 (enExample)
MX (1) MX392754B (enExample)
SG (1) SG11201809551TA (enExample)
WO (1) WO2017196235A1 (enExample)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113073066A (zh) * 2021-04-16 2021-07-06 北京华元生物技术研究院 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN114317326A (zh) * 2021-12-06 2022-04-12 浙江工商大学 一种用于缓解过敏反应的清酒乳杆菌及制备方法
CN115243567A (zh) * 2020-03-06 2022-10-25 学校法人麻布兽医学园 含有乳酸菌的组合物
CN116376758A (zh) * 2023-03-15 2023-07-04 广东南芯医疗科技有限公司 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4081229A1 (en) * 2019-12-24 2022-11-02 Iowa State University Research Foundation, Inc. Control of histamine to promote health and control enterocolitis using probiotic compositions and/or histamine degrading enzymes
CN115025130A (zh) * 2022-06-02 2022-09-09 广东南芯医疗科技有限公司 罗伊氏乳杆菌e9在制备治疗或预防过敏性疾病药物中的应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040068820A (ko) * 2003-01-27 2004-08-02 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를함유한 항알레르기 제품
WO2010020057A1 (en) * 2008-08-18 2010-02-25 Manel Jordana Treatment and/or Prevention of Peanut Induced Anaphylaxis
WO2012012390A1 (en) * 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US8222227B2 (en) * 2006-04-13 2012-07-17 Alcon Research, Ltd. RNAi-mediated inhibition of histamine receptor H1-related conditions
US20160000777A1 (en) * 2013-02-21 2016-01-07 University Of Rochester Methods of using histamine receptor agonists and antagonists

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO155805C (no) * 1981-02-06 1987-06-10 Ucb Sa Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter.
JP4212838B2 (ja) * 2002-06-26 2009-01-21 カルピス株式会社 抗アレルギー剤
AU2002951270A0 (en) * 2002-09-06 2002-09-19 Vri Biomedical Ltd Probiotic Bacterium and Methods of Use
CA2586316A1 (en) * 2004-11-11 2006-05-18 Argenta Discovery Ltd. Pyrimidine compounds as histamine modulators
JP2008127365A (ja) * 2006-11-24 2008-06-05 Kowa Co アレルギー性疾患の予防及び／又は治療剤
JP2011254773A (ja) * 2010-06-11 2011-12-22 Bio Plan:Kk 乳酸菌の菌株及びこれを利用したアレルギー抑制剤
US20130022586A1 (en) * 2011-07-21 2013-01-24 James Versalovic Production and use of bacterial histamine
JP6195268B2 (ja) * 2013-07-18 2017-09-13 国立大学法人徳島大学 鼻炎の予防治療装置
MX2017012359A (es) * 2015-03-26 2018-07-06 Biogaia Ab Cepas bacterianas productoras de histamina y su uso en cancer.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20040068820A (ko) * 2003-01-27 2004-08-02 (주) 피엘바이오 알레르기 질환 예방 및 치료 기능을 가진 유산균과 이를함유한 항알레르기 제품
US8222227B2 (en) * 2006-04-13 2012-07-17 Alcon Research, Ltd. RNAi-mediated inhibition of histamine receptor H1-related conditions
WO2010020057A1 (en) * 2008-08-18 2010-02-25 Manel Jordana Treatment and/or Prevention of Peanut Induced Anaphylaxis
WO2012012390A1 (en) * 2010-07-19 2012-01-26 Marvphyt Development Llc Botanical composition and methods of manufacture and use
US20160000777A1 (en) * 2013-02-21 2016-01-07 University Of Rochester Methods of using histamine receptor agonists and antagonists

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
GANESH: "hdcA+ L. reuteri 6475 inhibits H1R downstream signaling via dagK and causes immunosuppression of intestinal epithelium in gnotobiotic mice", 《FAS EB》 *
XIE H ET AL: "ROLES OF HISTAMINE AND ITS RECEPTORS IN ALLERGIC AND INFLAMMATORY BOWEL DISEASES", 《WORLD JOURNAL OF GASTROENTEROLOGY》 *
YAN WANG ET AL: "DGK alpha DNA vaccine relieves airway allergic inflammation in asthma model possibly via induction of T-cell anergy", 《 INT J CLIN EXP PATHOL》 *
ZHONG ET AL: "Diacylglycerol Kinase Deficiency Increases the Peanut Allergic Response in Mice", 《JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY》 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115243567A (zh) * 2020-03-06 2022-10-25 学校法人麻布兽医学园 含有乳酸菌的组合物
CN115243567B (zh) * 2020-03-06 2024-12-06 学校法人麻布兽医学园 含有乳酸菌的组合物
CN113073066A (zh) * 2021-04-16 2021-07-06 北京华元生物技术研究院 罗伊氏乳杆菌及其应用、组合物、药物和食品
CN114317326A (zh) * 2021-12-06 2022-04-12 浙江工商大学 一种用于缓解过敏反应的清酒乳杆菌及制备方法
CN114317326B (zh) * 2021-12-06 2023-09-12 浙江工商大学 一种用于缓解过敏反应的清酒乳杆菌及制备方法
CN116376758A (zh) * 2023-03-15 2023-07-04 广东南芯医疗科技有限公司 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用
CN116376758B (zh) * 2023-03-15 2024-07-02 广东南芯医疗科技有限公司 詹氏乳杆菌ls06及其在制备治疗或预防过敏性疾病药物中的应用

Also Published As

Publication number Publication date
AU2017262408A1 (en) 2018-11-15
CL2018003167A1 (es) 2018-12-21
US20220008491A1 (en) 2022-01-13
US12201656B2 (en) 2025-01-21
MX2018013660A (es) 2019-02-28
JP2019520801A (ja) 2019-07-25
SG11201809551TA (en) 2018-11-29
MX392754B (es) 2025-03-24
JP7030716B2 (ja) 2022-03-07
CA3023867A1 (en) 2017-11-16
BR112018072511A2 (pt) 2019-03-12
EP3454874A1 (en) 2019-03-20
US20190142877A1 (en) 2019-05-16
US11135255B2 (en) 2021-10-05
WO2017196235A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
Mathur et al. Health benefits of lactic acid bacteria (LAB) fermentates
US12201656B2 (en) Selection of bacterial strains useful in allergy treatment
CN114317320B (zh) 一种短双歧杆菌207-1及其应用
Barba-Vidal et al. Are we using probiotics correctly in post-weaning piglets?
AU2006296837B2 (en) Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
JP2021522867A (ja) ラクトバチルス・パラカゼイ株及びその使用
KR102024883B1 (ko) 락토바실러스 퍼멘텀 kbl 375 균주 및 그 용도
JP4942831B2 (ja) 抗アレルギー用組成物
BRPI0809448A2 (pt) Cepas de bifidobacterium probióticas
KR20150039816A (ko) 사료 첨가제 조성물
CN109415683A (zh) 新细菌物种
CA2895963A1 (en) Use of bifidobacterium animalis for treating or preventing body weight gain and insulin resistance
CN106795482B (zh) 允许在营养不良的情况下促进人和动物的幼年生长的乳杆菌组合物
JP6954995B2 (ja) 非コラーゲン性糖タンパク質分解用組成物
CN101808527A (zh) 用于诱导饱腹感和/或饱食的益生菌
Todorov et al. Bacteriocin production and resistance to drugs are advantageous features for Lactobacillus acidophilus La-14, a potential probiotic strain
JP7319920B2 (ja) 過敏性腸症候群または炎症性腸疾患の処置での使用のための微生物リゾチーム
JP6531893B2 (ja) 濾胞性ヘルパーｔ細胞増加剤
KR102866368B1 (ko) 내장 통증의 예방 및/또는 치료를 위한 락토콕커스 락티스 균주
BR122022016606B1 (pt) Lactobacillus paracasei mortos pelo aquecimento, medicamento, alimento ou bebida, ração, agente promotor da produção de il-12 e uso
JP4473570B2 (ja) 生体内での微生物の生残性を向上させる方法及び生残性が向上した微生物
AU2013201442B2 (en) Treatment of IBD and IBS using both probiotic bacteria and fermented cereal as treatment effectors
US20210322492A1 (en) Probiotic strains and uses thereof
HK40001496A (en) Selection of bacterial strains useful in allergy treatment
TW202335676A (zh) 腸管免疫賦活劑及IgA產生促進劑

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40001496

Country of ref document: HK

RJ01 Rejection of invention patent application after publication

Application publication date: 20190111

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 40001496

Country of ref document: HK